GT Biopharma
GTBP
GTBP
21 hedge funds and large institutions have $711K invested in GT Biopharma in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.39% more ownership
Funds ownership: 3.92% → 6.31% (+2.4%)
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$201K | |
| 2 | +$68K | |
| 3 | +$22.6K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.4K |
| 5 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
+$2.58K |
Top Sellers
| 1 | -$45.1K | |
| 2 | -$1.21K | |
| 3 | -$71 | |
| 4 |
FFA
Farther Finance Advisors
San Francisco,
California
|
-$14 |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
-$5 |